FDA Announces Approval of Office of Management and Budget for Charging Investigational Drugs

Summary

The Food and Drug Administration (FDA) is announcing that a collection of information entitled 'Charging for Investigational Drugs' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995, allowing the FDA to charge for investigational drugs.